Mondelez Q3 2026: Volume Turns Positive, but EPS Growth Trails Valuation

What happened

Mondelez reported Q3 2026 results with organic net revenue growth of 2.1% and volume/mix up 1.8%, marking a return to volume growth after several quarters of declines. Adjusted EPS rose 5.5% on a constant currency basis to $0.78, a moderate improvement from the prior-year trough. Year-to-date free cash flow was $1.7 billion, and the company returned $2.8 billion to shareholders, continuing its aggressive capital allocation. The positive volume/mix alleviates a key concern, but the lack of disclosed gross margin and only mid-single-digit EPS growth suggest margin recovery is not yet firmly established. Management's commentary highlights broad-based volume gains and share performance, yet the release omits critical profitability details.

Implication

For investors, the positive volume/mix reading alleviates a major worry, but the 5.5% constant-currency EPS growth is below the high-single-digit threshold that would justify an upgrade from the current WAIT rating. Without explicit gross margin data, the extent of profitability recovery remains uncertain, and cocoa deflation benefits may be offset by other costs or pricing actions. The company's continued large shareholder returns, while supportive, could pressure the balance sheet if earnings fail to accelerate. The stock's valuation at roughly 19-20x earnings still embeds a meaningful recovery, so risk-reward is balanced but not compelling. Investors should await the full-year figures and 2027 guidance before adjusting positions.

Thesis delta

The thesis improves modestly as volume/mix turned positive, addressing a key bear point, but the lack of gross margin detail and only mid-single-digit EPS growth keep the rating at WAIT. The recovery narrative is progressing but not yet proven enough to justify a more constructive stance.